BerandaAVH • ASX
add
AVITA Medical Inc
Tutup sebelumnya
$1,06
Rentang hari
$1,03 - $1,07
Rentang tahun
$1,00 - $4,52
Kapitalisasi pasar
156,56 jt AUD
Volume Rata-Rata
391,72 rb
Rasio P/E
-
Hasil dividen
-
Berita pasar
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 17,06 jt | -12,71% |
Biaya operasional | 23,03 jt | -23,65% |
Penghasilan bersih | -13,19 jt | 18,62% |
Margin laba bersih | -77,29 | 6,78% |
Penghasilan per saham | -0,71 | 23,47% |
EBITDA | -8,58 jt | 36,43% |
Tarif pajak efektif | -0,11% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 23,31 jt | -47,50% |
Total aset | 63,73 jt | -21,37% |
Total liabilitas | 70,39 jt | 2,28% |
Total ekuitas | -6,67 jt | — |
Saham yang beredar | 30,49 jt | — |
Harga terhadap nilai buku | -4,80 | — |
Tingkat pengembalian aset | -37,55% | — |
Tingkat pengembalian modal | -65,56% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | -13,19 jt | 18,62% |
Kas dari operasi | -5,22 jt | 27,65% |
Kas dari investasi | -5,34 jt | -172,23% |
Kas dari pembiayaan | 13,77 jt | 1.267,03% |
Perubahan kas bersih | 3,21 jt | 170,09% |
Arus kas bebas | -2,61 jt | 51,24% |
Tentang
Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia. Wikipedia
Didirikan
1999
Kantor pusat
Situs
Karyawan
260
